71 related articles for article (PubMed ID: 8918504)
1. Therapy of primary systemic CD30-positive anaplastic large-cell lymphoma of the adult.
Fanin R; Silvestri F
J Clin Oncol; 1996 Nov; 14(11):3049-50. PubMed ID: 8918504
[No Abstract] [Full Text] [Related]
2. Primary cutaneous CD30+ anaplastic large cell lymphoma treated with radiotherapy and methotrexate with development of xanthomas at the sites of prior disease.
Turrión-Merino L; Perez-Gala S; Hermosa-Zarza E; Urech-García-de-la-Vega M; Carrillo-Guijón R; Jaén-Olasolo P
J Cutan Pathol; 2016 Apr; 43(4):400-5. PubMed ID: 26695345
[TBL] [Abstract][Full Text] [Related]
3. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma.
Shehan JM; Kalaaji AN; Markovic SN; Ahmed I
J Am Acad Dermatol; 2004 Jul; 51(1):103-10. PubMed ID: 15243534
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
[TBL] [Abstract][Full Text] [Related]
5. Primary CD30/ALK-1 positive anaplastic large cell lymphoma of the skeletal muscle in a child.
Driss M; Abbes I; Mrad K; Sassi S; Oubich F; Barsaoui S; Romdhane KB
Pathologica; 2009 Apr; 101(2):97-100. PubMed ID: 19886557
[TBL] [Abstract][Full Text] [Related]
6. [(CD30+) anaplastic large-cell lymphoma (Ki-1 anaplastic lymphoma)].
Liozon E; Touati M; Lavignac C
Ann Med Interne (Paris); 1996; 147(8):553-66. PubMed ID: 9137682
[No Abstract] [Full Text] [Related]
7. Novel use of 308-nm excimer laser to treat a primary cutaneous CD30+ lymphoproliferative nodule.
Meisenheimer JL
J Drugs Dermatol; 2007 Apr; 6(4):440-2. PubMed ID: 17668543
[TBL] [Abstract][Full Text] [Related]
8. The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.
Gravanis I; Tzogani K; van Hennik P; de Graeff P; Schmitt P; Mueller-Berghaus J; Salmonson T; Gisselbrecht C; Laane E; Bergmann L; Pignatti F
Oncologist; 2016 Jan; 21(1):102-9. PubMed ID: 26621039
[TBL] [Abstract][Full Text] [Related]
9. Ki-1/CD30+ (anaplastic) large-cell lymphoma: maturation of a clinicopathologic entity with prospects of effective therapy.
Kadin ME
J Clin Oncol; 1994 May; 12(5):884-7. PubMed ID: 8164037
[No Abstract] [Full Text] [Related]
10. [Clinical and capillaroscopic regression of CD30 anaplastic lymphoma associated with limited cutaneous systemic sclerosis following autologous bone marrow transplantation].
Bellis R; Francès C; Barète S; Senet P
Ann Dermatol Venereol; 2014; 141(6-7):446-51. PubMed ID: 24951144
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic large cell lymphoma of scrotal skin.
Mehdi I; Praseeda I; Al-Bahrani BJ; Satayapal N; Monem AA; Al Kharusi S
J Pak Med Assoc; 2011 Nov; 61(11):1140-3. PubMed ID: 22126000
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic lymphoma kinase-positive primary cutaneous anaplastic large cell lymphoma--is it a new variant?
Kumaran MS; Jithendriya M; Nagaraj P; Tirumalae R; Jayaseelan E
Indian J Dermatol Venereol Leprol; 2012; 78(3):354-7. PubMed ID: 22565437
[TBL] [Abstract][Full Text] [Related]
13. CD30+ anaplastic large cell lymphomas.
Kaudewitz P; Kind P; Sander CA
Semin Dermatol; 1994 Sep; 13(3):180-6. PubMed ID: 7986686
[TBL] [Abstract][Full Text] [Related]
14. Two cases of CD30+, anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with oral manifestations.
Grandhi A; Boros AL; Berardo N; Reich RF; Freedman PD
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):e41-7. PubMed ID: 22940020
[TBL] [Abstract][Full Text] [Related]
15. A rare case of ALK negative CD30+ primary cutaneous anaplastic large cell lymphoma in a young adult.
Sridevi HB; Shanthala PR; Raghuveer CV; Prabhu AK; Akbar JK; Shivaprasad GS; Suresh PK; Navani S
J Cancer Res Ther; 2015; 11(3):656. PubMed ID: 26458652
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of bone marrow involvement in systemic anaplastic large cell lymphoma: are immunohistochemical studies necessary?
Weinberg OK; Seo K; Arber DA
Hum Pathol; 2008 Sep; 39(9):1331-40. PubMed ID: 18602674
[TBL] [Abstract][Full Text] [Related]
17. Successful use of brentuximab vedotin for refractory anaplastic large cell lymphoma as a bridging therapy to haploidentical stem cell transplantation and maintenance therapy post-transplantation.
Koh KN; Im HJ; Suh JK; Lee SW; Choi ES; Seo JJ
Pediatr Blood Cancer; 2015 Jun; 62(6):1063-5. PubMed ID: 25641881
[TBL] [Abstract][Full Text] [Related]
18. CD30 positive anaplastic large-cell lymphoma mimicking Langerhans cell histiocytosis.
Ezra N; Van Dyke GS; Binder SW
J Cutan Pathol; 2010 Jul; 37(7):787-92. PubMed ID: 19817947
[TBL] [Abstract][Full Text] [Related]
19. Clinical spectrum of primary cutaneous CD30-positive anaplastic large cell lymphoma: an analysis of the Mannheim Cutaneous Lymphoma Registry.
Booken N; Goerdt S; Klemke CD
J Dtsch Dermatol Ges; 2012 May; 10(5):331-9. PubMed ID: 22525148
[TBL] [Abstract][Full Text] [Related]
20. Sinusoidal CD30-positive large B-cell lymphoma: a morphologic mimic of anaplastic large cell lymphoma.
Lai R; Medeiros LJ; Dabbagh L; Formenti KS; Coupland RW
Mod Pathol; 2000 Mar; 13(3):223-8. PubMed ID: 10757332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
